INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
6,338,483
Share change
+4,189,238
Total reported value
$155,609,000
Price per share
$24.55
Number of holders
13
Value change
+$102,845,542
Number of buys
8
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q1 2018

As of 31 Mar 2018, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,338,483 shares. The largest 10 holders included MACKAY SHIELDS LLC, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, JANE STREET GROUP, LLC, LPL Financial LLC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, USAdvisors Wealth Management, LLC, ROYAL BANK OF CANADA, MORGAN STANLEY, and CITIGROUP INC. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.